PLXP
Fayez Sarofim & Co’s PLx Pharma Inc. Common Stock PLXP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,729
| Closed | -$1.79K | – | 291 |
|
|
2023
Q1 | $1.79K | Hold |
13,729
| – | – | ﹤0.01% | 281 |
|
|
2022
Q4 | $2.25K | Hold |
13,729
| – | – | ﹤0.01% | 281 |
|
|
2022
Q3 | $9K | Hold |
13,729
| – | – | ﹤0.01% | 278 |
|
|
2022
Q2 | $33K | Hold |
13,729
| – | – | ﹤0.01% | 289 |
|
|
2022
Q1 | $55K | Hold |
13,729
| – | – | ﹤0.01% | 320 |
|
|
2021
Q4 | $110K | Hold |
13,729
| – | – | ﹤0.01% | 336 |
|
|
2021
Q3 | $265K | Hold |
13,729
| – | – | ﹤0.01% | 288 |
|
|
2021
Q2 | $189K | Hold |
13,729
| – | – | ﹤0.01% | 313 |
|
|
2021
Q1 | $124K | Hold |
13,729
| – | – | ﹤0.01% | 287 |
|
|
2020
Q4 | $76K | Hold |
13,729
| – | – | ﹤0.01% | 270 |
|
|
2020
Q3 | $44K | Hold |
13,729
| – | – | ﹤0.01% | 265 |
|
|
2020
Q2 | $44K | Hold |
13,729
| – | – | ﹤0.01% | 258 |
|
|
2020
Q1 | $31K | Hold |
13,729
| – | – | ﹤0.01% | 238 |
|
|
2019
Q4 | $60K | Hold |
13,729
| – | – | ﹤0.01% | 269 |
|
|
2019
Q3 | $70K | Hold |
13,729
| – | – | ﹤0.01% | 251 |
|
|
2019
Q2 | $99K | Hold |
13,729
| – | – | ﹤0.01% | 250 |
|
|
2019
Q1 | $72K | Hold |
13,729
| – | – | ﹤0.01% | 246 |
|
|
2018
Q4 | $21K | Hold |
13,729
| – | – | ﹤0.01% | 237 |
|
|
2018
Q3 | $56K | Hold |
13,729
| – | – | ﹤0.01% | 240 |
|
|
2018
Q2 | $54K | Hold |
13,729
| – | – | ﹤0.01% | 244 |
|
|
2018
Q1 | $46K | Hold |
13,729
| – | – | ﹤0.01% | 247 |
|
|
2017
Q4 | $95K | Hold |
13,729
| – | – | ﹤0.01% | 245 |
|
|
2017
Q3 | $89K | Buy |
+13,729
| New | +$89K | ﹤0.01% | 240 |
|